Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287781
Status:
COMPLETED
Last Update Posted:
2008-01-25
First Post:
2006-02-06
Brief Title:
A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
Sponsor:
Kern Medical Center
Organization:
Kern Medical Center
Study Overview
Official Title:
A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study Using a nebulizer to administer the drug would improve the feasibility of using the treatment It would also spare the patient narcotics with their attendant side effects Because of the potential for placebo effect a placebo control is necessary in this study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None